/

Invitae Corporation

NVTA US

NVTA USInvitae Corporation

United States Composite

0.00

USD

+0.00

(+16.13%)

-5.58EPS Dil.

1.03MMarket Cap

Next Earnings

February 26

Held by Insiders

1.51%

Held by Institutions

47.96%

Short % of Float

23.65%

YTD Yield

-98.70%

3Y Yield

-99.95%

Capital Structure

FRC

•

in mil. unless spec.

Mar'23

Jun'23

Sep'23

ST Debt

LT Borrowings

1,380

1,420

1,324

LT Finance Leases

146

141

136

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

261

267

286

Market Capitalization

352

301

173

Working Capital

FRC

•

in mil. unless spec.

Mar'23

Jun'23

Sep'23

Total Current Assets

504

451

378

Cash, Cash Equivalents & STI

379

325

255

Accounts Receivable, Net

Inventories

Total Current Liabilities

190

152

158

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

- -

53.95%

12.17%

Net Income, GAAP

-131.51%

-184.74%

-719.53%

Free Cash Flow

-58.96%

-47.32%

11.22%

Total Cash Common Dividend

- -

Total Equity

-3.95%

108.30%

-96.57%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

104

116

114

126

460

2022

124

137

134

122

516

2023

117

121

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

-0.56

0.66

-0.91

-0.90

-1.80

2022

-0.80

-10.87

-1.27

-0.41

-13.18

2023

-0.77

-0.78

-3.42

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Company Description

CEO: Mr. Kenneth D. Knight
Full Time Employees: 1,700
Sector: Healthcare
Industry: Diagnostics & Research
Address: 1400 16th Street San Francisco CA United States 94103
CIK: 0001501134
Website: www.invitae.com
Business: Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.

Company News

Zacks
a month ago
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates

Company Description

CEO: Mr. Kenneth D. Knight
Full Time Employees: 1,700
Sector: Healthcare
Industry: Diagnostics & Research
Address: 1400 16th Street San Francisco CA United States 94103
CIK: 0001501134
Website: www.invitae.com
Business: Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.